Short Interest in Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Grows By 20.5%

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the recipient of a large increase in short interest in the month of January. As of January 30th, there was short interest totaling 2,638 shares, an increase of 20.5% from the January 15th total of 2,189 shares. Based on an average daily volume of 921 shares, the short-interest ratio is presently 2.9 days. Based on an average daily volume of 921 shares, the short-interest ratio is presently 2.9 days.

Hikma Pharmaceuticals Stock Up 0.2%

Hikma Pharmaceuticals stock opened at $43.15 on Tuesday. Hikma Pharmaceuticals has a fifty-two week low of $39.93 and a fifty-two week high of $59.26. The firm’s fifty day moving average price is $42.13 and its 200-day moving average price is $44.83.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.